Back to top

Image: Bigstock

New Strong Buy Stocks for September 14th

Read MoreHide Full Article

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Aarons, Inc. (AAN - Free Report) : This major omni-channel provider of lease-purchase solutions has seen the Zacks Consensus Estimate for its current year earnings increasing 27.8% over the last 60 days.

Aarons, Inc. Price and Consensus

 

Aarons,  Inc. Price and Consensus

Aarons, Inc. price-consensus-chart | Aarons, Inc. Quote

BJs Wholesale Club Holdings, Inc. (BJ - Free Report) This company that emerged as one of the preferred destinations for shoppers when it comes to essentials and other items has seen the Zacks Consensus Estimate for its current year earnings increasing 15.1% over the last 60 days.

Caseys General Stores, Inc. (CASY - Free Report) : This company that operates convenience stores has seen the Zacks Consensus Estimate for its current year earnings increasing 21.1% over the last 60 days.

Rio Tinto PLC (RIO - Free Report) : This international mining company has seen the Zacks Consensus Estimate for its current year earnings increasing 28.5% over the last 60 days.

Rio Tinto PLC Price and Consensus

 

Rio Tinto PLC Price and Consensus

Rio Tinto PLC price-consensus-chart | Rio Tinto PLC Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Cornerstone Building Brands, Inc. (CNR - Free Report) : This manufacturer of exterior building products primarily in North America has seen the Zacks Consensus Estimate for its current year earnings increasing 68.3% over the last 60 days.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>